Developing a Low-Intensity Primary Care Intervention for Anxiety Disorders (AIM-PC)
Anxiety Disorders
About this trial
This is an interventional treatment trial for Anxiety Disorders focused on measuring anxiety disorders, cognitive bias modification, primary care, attention, interpretation, computer
Eligibility Criteria
Inclusion Criteria:
- Study site patient
- Age ≥18
- Primary diagnosis of Generalized anxiety disorder (GAD), Social Phobia (SP), and/or panic disorder with or without agoraphobia (PD/A)
- At least moderate anxiety severity (GAD-7 score > 10)
- English-speaking
- If on psychopharmacotherapy, stable dose for 3 months; to minimize learning effects, patients taking benzodiazepines will complete AIM prior to their first dose of the day
- No current psychotherapy
- No current severe psychiatric symptoms requiring immediate attention (e.g., imminent suicidality, psychosis)
Sites / Locations
- Family Care Center of Memorial Hospital of Rhode Island
Arms of the Study
Arm 1
Experimental
Attention & Interpretation Modification
The final product will be web-delivered, so it may be completed at the clinic or home. Treatment will consist of 8, 30-minute, twice-weekly sessions designed to: a) decrease attention bias to threat and b) extinguish threat interpretations/reinforce benign interpretations of ambiguity. Attention bias will be modified via a dot probe task that increases attentional control by directing attention away from threat faces via probe location. Patients will complete 256 trials per session. Interpretation bias will be modified via a word-sentence association task which provides positive feedback when participants endorse benign interpretations of ambiguous sentences and negative feedback for threat interpretations. Participants will complete 150 training trials per session